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ABSTRACT
As the world’s economies come out of the lockdown imposed by the COVID-19
pandemic, there is an urgent need for technologies to mitigate COVID-19
transmission in confined spaces such as buildings. This feasibility study looks at one
such technology, upper-room ultraviolet (UV) air disinfection, that can be safely
used while humans are present in the room space, and which has already proven its
efficacy as an intervention to inhibit the transmission of airborne diseases such as
measles and tuberculosis. Using published data from various sources, it is shown that
the SARS-CoV-2 virus, the causative agent of COVID-19, is highly likely to be
susceptible to UV-C damage when suspended in air, with a UV susceptibility
constant likely to be in the region 0.377–0.590 m2/J, similar to that for other
aerosolised coronaviruses. As such, the UV-C flux required to disinfect the virus is
expected to be acceptable and safe for upper-room applications. Through analysis of
expected and worst-case scenarios, the efficacy of the upper-room UV-C approach
for reducing COVID-19 transmission in confined spaces (with moderate but
sufficient ceiling height) is demonstrated. Furthermore, it is shown that with SARS-
CoV-2, it should be possible to achieve high equivalent air change rates using
upper-room UV air disinfection, suggesting that the technology might be particularly
applicable to poorly ventilated spaces.
Subjects Microbiology, Virology, Infectious Diseases, Environmental Contamination and
Remediation
Keywords COVID-19, SARS-CoV-2, Ultraviolet, Air transmission mitigation, Upper room UV-C,
Presence of humans
INTRODUCTION
Since the emergence of COVID-19 in January 2020 there has been considerable interest
in the use of ultraviolet (UV) light to disinfect blood plasma (Eickmann et al., 2020;
Keil et al., 2020; Ragan et al., 2020), equipment (Card et al., 2020; Derraik et al., 2020;
Hamzavi et al., 2020; Heimbuch & Harnish, 2019) and air (Morawska et al., 2020), in the
hope that this might reduce transmission of the disease. In particular, upper-room
ultraviolet germicidal irradiation (UVGI), a technology that disinfects room air, has
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been muted as a potential intervention that might prove effective against COVID-19
(Morawska et al., 2020; Nardell & Nathavitharana, 2020; Skorzewska, 2020). Upper-room
UVGI utilizes UV-C light at wavelengths close to 254 nm to create an irradiation field
above the heads of room occupants (Fig. 1) that disinfects aerosolised bacteria and viruses
suspended in the air (Beggs et al., 2006; Beggs & Sleigh, 2002; Noakes, Khan & Gilkeson,
2015). Because UV-C light is harmful to humans, such systems utilize louvers or
shields that obscure the UV lamps from eyesight so that room occupants are kept safe.
As such, upper-roomUVGI is a well-established technology (First et al., 1999a, 1999b) that
has proven effective as a public health intervention to prevent the spread of airborne
diseases such as measles (Nardell & Nathavitharana, 2019) and tuberculosis (TB)
(Escombe et al., 2009; Mphaphlele et al., 2015) in buildings.
Given that COVID-19 can be transmitted by the inhalation of aerosolised respiratory
droplets containing the SARS-CoV-2 virus (Beggs, 2020; Miller et al., 2020; Morawska
et al., 2020; Stadnytskyi et al., 2020), and that several studies have recovered viral RNA
from hospital air samples (Chia et al., 2020; Guo et al., 2020; Jiang et al., 2020; Santarpia
et al., 2020), there is reason to believe that upper-room UVGI might be effective at
“killingx201D; (inactivating) SARS-CoV-2 virions in the air, thus reducing the
transmission of COVID-19 in buildings and other enclosed spaces. However, this
presupposes that the technology is capable of delivering irradiation doses high enough to
inactivate SARS-CoV-2 virions in respiratory droplets suspended in the air, something that
has not yet been proven. Given this and the urgent need to develop interventions to
break the chain of infection associated with COVID-19, we designed the short feasibility
study reported here with the aim of evaluating whether or not upper-room UVGI might be
an effective intervention against COVID-19.
Figure 1 An upper-room UVGI installation. Full-size DOI: 10.7717/peerj.10196/fig-1
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METHODS
Theory
At any point in time the amount of viral inactivation (disinfection) achieved for a given
UV radiant flux (irradiance) can be described using the following first order decay
equation (McDevitt, Rudnick & Radonovich, 2012).
Nt ¼ N0  eZ:E:t (1)
where: N0 and Nt are the number of viable viral particles (virions) at time zero and
t seconds respectively; Z is the UV susceptibility constant for the virus (m2/J); E is the
radiant (irradiation) flux (W/m2); and t is time in seconds.
The UV irradiation dose received by the virus is simply:
H ¼ E  t (2)
where: H is the observed UV irradiation dose (J/m2).
By combining Eqs. (1) and (2), and rearranging we can obtain a value for Z.
Z ¼  1
H
 ln Nt
N0
 
¼  1
H
 ln fð Þ (3)
where: f is the survival fraction.
Because the relationship between the UV dose and the natural logarithm of the survival
fraction is broadly linear for most viral species, it means that the behavior of any given
virus exposed to UV-C light can be succinctly described by the value of Z, irrespective
of the actual UV dose applied. As such, for any given viral species, if the value of Z is
known, then it should be possible to predict with reasonable accuracy how the virus will
behave when exposed to a given UV-C dose in any context. Microbes that exhibit larger Z
values are more susceptible to UV damage, whereas those with small Z values are more
difficult to inactivate.
UV inactivation plots for most viral species tend to be straight lines, although some
might exhibit a curve (Kariwa, Fujii & Takashima, 2006). Notwithstanding this, the model
described in Eq. (1) is still a good approximation for most viral species (McDevitt,
Rudnick & Radonovich, 2012) up until the point where the “target” becomes saturated
with UV photons. At this point, because all the virions have already been inactivated,
increasing the UV dose further has no effect and so the linear relationship between UV dose
and the log reduction becomes decoupled, with the result that the Z value no long applies.
Instead of quantifying UV inactivation in terms of survival fraction, many researchers,
particularly those working in biology, describe the reduction in the microbial count in
terms of log reduction, which can be converted to survival fraction as follows:
f ¼ 1
10A
(4)
where: A is the log10 reduction in the number of virions.
Specifically, with regard to upper-room UVGI, once the Z value has been obtained for
the target microbe, it is then possible to determine the irradiation flux required to disinfect
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it, using the methodology described in Beggs & Sleigh (2002). This method makes the
assumption that the room air is well mixed, which is a reasonable approximation for most
applications (Beggs & Sleigh, 2002). If this is the case, then the average particle residence
time, tres (in seconds) in the room space will be:
tres ¼ 1n 3;600 (5)
where: n is the room ventilation rate in air changes per hour (AC/h).
From Eq. (5) it can be approximated that the average particle residence time in the
upper-room UV field, tuv (in seconds) will be:
tuv ¼ tres  huvhr (6)
where: hr is the floor-to-ceiling height (m), and huv is the depth of the upper-room UV
zone (m) (see Fig. 1).
Because Z values are often determined experimentally using microbes suspended in
liquids or on surfaces, it may be necessary to adjust the Z value for use with upper-room
UVGI systems (Beggs et al., 2006; Yang et al., 2017), as follows:
Zur ¼ Z  cur (7)
where: Zur is the effective upper-room Z value (m
2/J), and cur is a correction coefficient.
For practical purposes, Zur can be assumed to be the same as the Z value achieved when
a given microbe is irradiated in an aerosol.
So if we assume that the air in a room is well mixed, by combining Eqs. (2), (3) and (6)
it is possible to compute the average irradiation flux, Er, that is required to achieve a
desired survival fraction, fr.
Er ¼  1Zur  tuvð Þ  ln frð Þ (8)
Alternatively, the disinfection achieved by an upper-room UVGI system can be thought
of as being equivalent to additional air changes in the room space (McDevitt et al., 2008).
In this scenario, the UV rate constant, kuv, which can be thought of as the equivalent
air change rate per second, can be determined using (Beggs et al., 2006):
kuv ¼ Zur  E  huvhr (9)
So, in a ventilated room in which contamination ceases at time zero, we can utilize both
the UV rate constant, kuv, and a rate constant, kv, for the ventilation (i.e., n ÷ 3,600), to
produce a decay model for the room space.
Ct ¼ C0  e kvþkuvþkdð Þt (10)
where: C0 and Ct are the concentrations of viable viral particles in the room space
(virions/m3) at time zero and t seconds respectively; kv is the ventilation rate constant; kd is
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the particulate deposition rate constant (e.g., 0.0014 s−1 (Stadnytskyi et al., 2020)); and t is
time in seconds.
Analysis of published data
A search of the relevant scientific literature (i.e., published literature, pre-prints and
relevant websites) was undertaken to identify published data relating to the UV irradiation
of the three closely related coronaviruses: SARS-CoV-2, the causative agent of COVID-19;
SARS-CoV-1, the causative agent of severe acute respiratory syndrome (SARS); and
MERS-CoV, the causative agent of middle east respiratory syndrome (MERS).
Because the experimental methods used in the various UV studies varied greatly, as
did the level of detail reported, it was necessary to adopt a standardized approach so that
valid comparisons could be made. It was therefore decided that, rather than estimating
the Z value for a nominal log one reduction (i.e., D90) as others have done (Kowalski, 2010),
we would instead use the log reduction values and UV doses reported in the various
studies to calculate the respective Z values using Eq. (3). In so doing, we were able to utilize
the results from studies that would otherwise be excluded because the log reductions
achieved were far in excess of one. Where researchers performed experiments using a
range of UV doses, we calculated the Z value for two UV doses, one near the start of the
inactivation process and the other just before the saturation point. So as to avoid bias due
to pseudo-replication, when computing the average Z values for the respective viral
species, we first aggregated the Z values reported for the various individual studies and
then used the aggregated values to calculate the overall mean Z values for the respective
viruses.
In order to compare the Z values for the coronaviruses with those for influenza, we
utilized experimental results produced by Heimbuch & Harnish (2019) who irradiated
coupons of respirator material inoculated with SARS-CoV-1 and MERS-CoV, as well as
four strains of influenza A, allowing direct comparisons to be made between the viral
species.
Estimating an effective upper-room Z value for aerosolised
SARS-CoV-2
In order to evaluate how SARS-CoV-2 might behave in the presence of UV-C when
aerosolised, we reviewed the available literature on the subject (Jensen, 1964; Kowalski,
2010; Kowalski et al., 2000; McDevitt, Rudnick & Radonovich, 2012; Walker & Ko, 2007)
with the aim of estimating a value for the coefficient, cur, in Eq. (7), which we then used
to estimate the effective upper-room Z value, Zur. In order to reflect the uncertainty
associated with this, we compared effective Z values for aerosolised coronaviruses reported
in the literature with values obtained for SARS-CoV-2 in liquids to obtain the range of
possible values for cur.
Computation of required upper-room UV irradiation flux
Having estimated the value of Zur for SARS-CoV-2 from the literature, we then used
Eqs. (6) and (8) to estimate the average upper-room irradiation flux that would be required
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to achieve a 50–90% reduction in aerosolised SARS-CoV-2 virions (through the action of the
UV-C alone) in a 4.2 × 4.2 × 2.5 m high room space for a range of ventilation rates.
These dimensions were chosen because they are typical for an upper-room UVGI
installation in which the lamp height is 2.1 m above the floor (First et al., 1999b). In the
model we assumed that the air was completely mixed, which meant that according to Eq. (6),
aerosol particles would spend on average 16% of their room residency time in the UV zone.
In addition to computing the required UV flux, we also wanted to know how a standard
upper-room UV fitting might perform when challenged by SARS-CoV-2. In accordance
with the guidelines stated by First et al. (1999b), we assumed that the room contained a single
30 W (input) UV-C fitting capable of delivering an average upper-room flux of 50 mW/cm2,
and modeled its performance in terms of equivalent ventilation rate using Eq. (9).
RESULTS
Analysis of the published literature
The results of the literature search are summarized in Table 1, which shows the UV-C
(254 nm) doses applied and log reductions achieved in six studies investigating
SARS-CoV-1 (Darnell et al., 2004; Darnell & Taylor, 2006; Duan et al., 2003; Eickmann
et al., 2020; Heimbuch & Harnish, 2019; Kariwa, Fujii & Takashima, 2006), two
studies investigating MERS-CoV (Bedell, Buchaklian & Perlman, 2016; Heimbuch &
Harnish, 2019), and two studies investigating SARS-CoV-2 (Bianco et al., 2020;
Signify, 2020). Table 1 also includes the results of one study that investigated the impact of
Table 1 UV-C doses applied and log reductions achieved in various studies relating to the SARS-CoV-1 and MERS-CoV viruses.
Virus UV wave length
(nm)
Medium & context Irradiance
(mW/cm2)
Duration
(min & s)
UV Dose
(mJ/cm2)
Inactivation
(log reduction)
References
SARS-CoV-1 UV-C (nr) Liquid in well plate >90 15 min >81 >log 0.602 Duan et al. (2003)
SARS-CoV-1 254 Liquid in well plate 4,016 1 min 241 log 1.4* Darnell et al. (2004)
SARS-CoV-1 254 Liquid in well plate 4,016 6 min 1,446 log 4.5* Darnell et al. (2004)
SARS-CoV-1 254 Liguid in well plate 4,016 20 min 4,819 log 4.1* Darnell & Taylor (2006)
SARS-CoV-1 UV-C (nr) Liquid in well plate 134 5 min 40 log 3.2* Kariwa, Fujii & Takashima (2006)
SARS-CoV-1 UV-C (nr) Liquid in well plate 134 15 min 121 log 5.325 Kariwa, Fujii & Takashima (2006)
SARS-CoV-1 254 Respirator surface 2,300 7.25 min 1,000 ≥log 4.81 Heimbuch & Harnish (2019)
SARS-CoV-1 254 Platelet concentrates nr nr 50 log 3.05 Eickmann et al. (2020)
SARS-CoV-1 254 Platelet concentrates nr nr 100 ≥log 3.5 Eickmann et al. (2020)
MERS-CoV 254 Respirator surface 2,300 7.25 min 1,000 ≥log 4.5 Heimbuch & Harnish (2019)
MERS-CoV UV-C (nr) Droplet on glass slip nr 5 min nr ≥log 5.91 Bedell, Buchaklian & Perlman (2016)
ARS-CoV-2 254 Liguid in well plate 1,082 nr 3.7 log 3.3 Bianco et al. (2020)
SARS-CoV-2 UV-C (nr) Inoculated material nr 6 s 5.0 log 2.0 Signify (2020)
SARS-CoV-2 UV-C (nr) Inoculated material nr 25 s 22.0 log 6.0 Signify (2020)
SARS-CoV-2 280 Liquid in petri dish 3,750 1 s 3.75 log 0.9 Inagaki et al. (2020)
SARS-CoV-2 280 Liquid in petri dish 3,750 10 s 37.5 log 3.0 Inagaki et al. (2020)
Notes:
* Estimated from plots and data presented in source material.
nr, not reported in source material.
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deep-UV light at 280 nm (i.e., the boundary between UV-B and UV-C) on SARS-CoV-2
(Inagaki et al., 2020). In addition, three studies were found that used a combination of
UV-A and UV-B light (270–360 nm), together with the photosensitiser, riboflavin, to
disinfect SARS-CoV-2 (Keil et al., 2020; Ragan et al., 2020) andMERS-CoV (Keil, Bowen &
Marschner, 2020) in blood products (Table 2). Although these studies did not utilize UV-C
light, it was nevertheless decided to report the results of these studies here so that direct
comparisons could be made between SARS-CoV-2 and MERS-CoV. The MERS-CoV
irradiation study by Bedell, Buchaklian & Perlman (2016) is included for completeness,
even though the authors did not report the UV dose received by the virus, making it
impossible to compute a Z value for this study.
The computed Z values for the respective experiments are shown in Table 3 (UV-C and
deep-UV) and Table 4 (UV-A/B plus riboflavin). From these it can be seen that the Z
values for the MERS-CoV virus were similar in magnitude to those for both SARS-CoV-1
(UV-C) and SARS-CoV-2 (UV-A/B). With UV-C irradiation the mean Z value for
SARS-CoV-1 was 0.00489 (SD = 0.00611) m2/J, whereas that for MERS-CoV was 0.00104
m2/J. Likewise, for UV-A/B plus riboflavin the corresponding Z values were 0.00020
(SD = 0.00009) m2/J and 0.00016 m2/J for SARS-CoV-2 and MERS-CoV respectively.
However, by comparison SARS-CoV-2 appeared to be more susceptible to UV damage
than either SARS-CoV-1 or MERS-CoV when irradiated with UV-C (mean Z = 0.14141
(SD = 0.09045) m2/J) and deep-UV light (mean Z = 0.03684 m2/J).
The calculated Z values for influenza UV-C irradiation experiments undertaken by
Heimbuch & Harnish (2019) are presented in Table 5. These experiments, which were
carried out using inoculated coupons of respirator material, revealed that in this context
the Z values for the various influenza A strains were of the same order of magnitude as
those for SARS-CoV-1 and MERS-CoV.
Effective upper-room Z values for aerosolised SARS-CoV-2
A review of the literature revealed that relatively few experimental studies have been
performed involving the UV irradiation of aerosolised viruses, with only three undertaken
Table 2 UV-A/B doses applied and log reductions achieved in the various studies relating to the disinfection of SARS-CoV-2 and MERS-CoV
in blood products when riboflavin is used.
Virus UV wave
length
(nm)
Medium & context Irradiance
(mW/cm2)
Duration
(min)
UV Dose
(mJ/mL)
Inactivation
(log reduction)
References
MERS-CoV 270–360 Blood plasma + riboflavin
(pooled)
nr nr 6,240 ≥log 4.07 Keil, Bowen & Marschner
(2020)
MERS-CoV 270–360 Blood plasma + riboflavin
(single donor)
nr nr 6,240 ≥log 4.42 Keil, Bowen & Marschner
(2020)
SARS-CoV-2 270–360 Blood plasma + riboflavin nr 4 1,872 ≥log 2.61 Ragan et al. (2020)
SARS-CoV-2 270–360 Blood plasma + riboflavin nr 4 3,744 ≥log 4.72 Ragan et al. (2020)
SARS-CoV-2 270–360 Blood plasma + riboflavin nr nr 6,240 ≥log 3.4 Keil et al. (2020)
SARS-CoV-2 270–360 Platelets + riboflavin nr nr 6,240 ≥log 4.53 Keil et al. (2020)
Note:
nr, not reported in source material.
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on a coronavirus (Buonanno et al., 2020; Walker & Ko, 2007). A summary of the findings
of several key studies are presented in Table 6, which reveals that most viral species appear
to be relatively easy to disinfect when suspended in droplets in the air. In particular,
aerosolised viruses appear to be more vulnerable to UV damage than when they are
suspended in a liquid or on a substrate. For example, for the 24 irradiation experiments
involving adenoviruses suspended in liquid, reported by Kowalski (2010), the average Z
value was 0.00586 m2/J, which is an order of magnitude less than the values of 0.0546
and 0.0390 m2/J for aerosolised adenoviruses, attributed to Jensen (1964) andWalker & Ko
(2007) respectively. Regarding coronaviruses, Walker & Ko (2007) also performed
experiments on aerosolised murine (mouse) hepatitis virus (MHV) coronavirus in a
single pass test rig. This revealed a Z value of 0.377 ± 0.119 m2/J for this virus.
Table 3 Calculated Z values for the UV-C irradiation experiments.
Virus UV Dose
(mJ/cm2)
Inactivation
(log reduction)
UV susceptibility
constant, Z (m2/J)
References
SARS-CoV-1 >81 >log 0.602 0.00171 Duan et al. (2003)
SARS-CoV-1 241 log 1.4* 0.00134* Darnell et al. (2004)
SARS-CoV-1 1,446 log 4.5* 0.00072* Darnell et al. (2004)
SARS-CoV-1 4,819 log 4.1* 0.00020* Darnell & Taylor (2006)
SARS-CoV-1 40 log 3.2* 0.01833* Kariwa, Fujii & Takashima (2006)
SARS-CoV-1 121 log 5.325 0.01017 Kariwa, Fujii & Takashima (2006)
SARS-CoV-1 1,000 ≥log 4.81 0.00111 Heimbuch & Harnish (2019)
SARS-CoV-1 50 log 3.05 0.01405 Eickmann et al. (2020)
SARS-CoV-1 100 ≥log 3.5 0.00806 Eickmann et al. (2020)
MERS-CoV 1,000 ≥log 4.5 0.00104 Heimbuch & Harnish (2019)
SARS-CoV-2 3.7 log 3.3 0.20536 Bianco et al. (2020)
SARS-CoV-2 5 log 2.0 0.09210 Signify (2020)
SARS-CoV-2 22 log 6.0 0.06280 Signify (2020)
SARS-CoV-2 3.75** log 0.9 0.05526 Inagaki et al. (2020)
SARS-CoV-2 37.5** log 3.0 0.01842 Inagaki et al. (2020)
Notes:
* Estimated from plots and data presented in source material.
** Using deep-UV light at 222 nm.
Table 4 Calculated Z values for the UV-A/B irradiation plus riboflavin experiments.
Virus UV Dose
(mJ/mL)
Inactivation
(log reduction)
UV susceptibility
constant, Z (m2/J)
References
MERS-CoV 6,240 ≥log 4.07 0.00015 Keil, Bowen & Marschner (2020)
MERS-CoV 6,240 ≥log 4.42 0.00016 Keil, Bowen & Marschner (2020)
SARS-CoV-2 1,872 ≥log 2.61 0.00032 Ragan et al. (2020)
SARS-CoV-2 3,744 ≥log 4.72 0.00029 Ragan et al. (2020)
SARS-CoV-2 6,240 ≥log 3.4 0.00013 Keil et al. (2020)
SARS-CoV-2 6,240 ≥log 4.53 0.00017 Keil et al. (2020)
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Buonanno et al. (2020) also performed irradiation experiments on aerosolised
coronaviruses, but using UV light at 222 nm (far-UV) rather than 254 nm. They found the
Z values for human coronavirus 229E and human coronavirus OC43 to be 0.410 m2/J
and 0.590 m2/J respectively. Collectively, these Z values are an order of magnitude greater
than the values obtained for SARS-CoV-2 in liquid, implying that when aerosolised,
coronaviruses in general and SARS-CoV-2 in particular, are much easier to disinfect
compared with when they are presented in liquids or on surfaces. Although we are
comparing different species of coronavirus here, evidence from Bedell, Buchaklian &
Perlman (2016), who irradiated MHV coronavirus and MERS-CoV in Petri dishes,
suggests that it is nonetheless valid. They found that 5 min exposed to a UV-C light source
resulted in a 2.71 log reduction for the MHV coronavirus, whereas the same exposure
resulted in a 5.91 log reduction for MERS-CoV. This suggests that MHV coronavirus is
actually more resistant to UV damage than MERS-CoV, and as such, supports Walker &
Ko (2007) conclusion that coronaviruses are much easier to inactivate in the air compared
with on surfaces and in liquids.
Table 5 Calculated Z values for the UV-C irradiation experiments for different strains of influenza A
tested by Heimbuch & Harnish.
Virus Medium & context UV Dose
(mJ/cm2)
Inactivation
(log reduction)
UV susceptibility
constant, Z (m2/J)
Influenza A (H1N1) Respirator surface 1,000 ≥log 6.01 0.00138
Avian influenza A (H5N1) Respirator surface 1,000 ≥log 4.46 0.00103
Influenza A (H7N9),
A/Anhui/1/2013 strain
Respirator surface 1,000 ≥log 5.15 0.00119
Influenza A (H7N9),
A/Shanghai/1/2013
Respirator surface 1,000 ≥log 5.31 0.00122
Table 6 Summary of reported effective Z values for single-pass UV irradiation experiments performed on aerosolised viruses in air.
Researchers Virus UV-C wavelength (nm) Effective Z value
(m2/J)
Reporter
Jensen (1964) Adenovirus 254 0.0546 Kowalski et al. (2000)
Jensen (1964) Coxsackie B-1 254 0.1108 Kowalski et al. (2000)
Jensen (1964) Influenza A 254 0.1187 Kowalski et al. (2000)
Jensen (1964) Sindbis virus 254 0.1040 Kowalski (2010)
Jensen (1964) Vaccinia virus 254 0.1528 Kowalski et al. (2000)
Walker & Ko (2007) Adenovirus 254 0.0390 Walker & Ko (2007)
Walker & Ko (2007) MHV coronavirus 254 0.3770 Walker & Ko (2007)
McDevitt, Rudnick &
Radonovich (2012)
Influenza A 254 0.2700 McDevitt, Rudnick &
Radonovich (2012)
McDevitt et al. (2007) Vaccinia virus 254 2.5400 McDevitt et al. (2007)
Buonanno et al. (2020) Human coronavirus 229E 222 0.4100 Buonanno et al. (2020)
Buonanno et al. (2020) Human coronavirus OC43 222 0.5900 Buonanno et al. (2020)
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Comparing the computed Z values for UV-C irradiation experiments on the MHV
coronavirus conducted in air (0.37700 m2/J (Walker & Ko, 2007)) with those for the
SARS-CoV-2 virus in liquid ranging from 0.06280 m2/J (Signify, 2020) to 0.20536 m2/J
(Kariwa, Fujii & Takashima, 2006), it would appear that irradiating the coronavirus in
liquid requires a UV-C dose that is in the region 1.8–6.0 times higher than that required
when the virus is suspended in air. From this we estimated that the value of the adjustment
coefficient cur would be in a range 0.167–0.545.
Upper-room UVGI computation results
Because no UV irradiation experiments have to date been performed on aerosols
containing the SARS-CoV-2 virus, it was necessary when undertaking the feasibility study
to make assumptions regarding an appropriate value of Zur to use in the upper-room
UVGI analysis. With respect to this, because the published mean Z values for the
aerosolised coronaviruses were all in the region 0.377–0.590 m2/J, we felt that an assumed
Z value in this range would be indicative of how airborne SARS-CoV-2 might behave in a
UV-C field. A decision was therefore made to use Walker and Ko’s Z value figure of
0.377 m2/J to evaluate the expected performance of the upper-room UVGI installation,
because this was considered a conservative value. In addition, because of the uncertainty
associated with this assumed value, we introduced a “factor of safety” into our analysis
by also modeling a worst-case scenario in which Zur was 0.0377 m
2/J.
Table 7 presents the results of the room analysis using these two values for Zur, for a
range of ventilation rates. From this it can be seen that there is a direct inverse relationship
between particle residence time in the UV field, tuv, and the required irradiation flux,
Er, as predicted by Eq. (8). This means that for any given Z value, the value of Er will double
as the room ventilation rate doubles. The table also reveals that there is a direct inverse
relationship between Zur and Er. From the calculated values in this table it can be seen
Table 7 Predicted average upper-room UV irradiance fluxes required to achieve 50%, 70% and 90% inactivation for SARS-CoV-2 assuming a
range of Zur values and ventilation rates (Assuming Zur = 0.377 or 0.0377 m
2/J).
Ventilation rate
(AC/h)
Average particle residence
time in UV field.
(min)
UV susceptibility
constant, Zur
(m2/J)
Average irradiance
required for 50%
inactivation
(mW/cm2)
Average irradiance
required for 70%
inactivation
(mW/cm2)
Average irradiance
required for 90%
inactivation
(mW/cm2)
1 9.6 0.3770 0.319 0.554 1.060
2 4.8 0.3770 0.638 1.109 2.121
4 2.4 0.3770 1.277 2.218 4.241
6 1.6 0.3770 1.915 3.327 6.362
8 1.2 0.3770 2.554 4.436 8.482
1 9.6 0.0377 3.192 5.544 10.604
2 4.8 0.0377 6.384 11.088 21.207
4 2.4 0.0377 12.768 22.177 42.414
6 1.6 0.0377 19.152 33.266 63.621
8 1.2 0.0377 25.536 44.355 84.829
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that if Zur = 0.377 m
2/J, then with an average UV flux of just 10 mW/cm2 it should be
possible to achieve >90% inactivation of SARS-CoV-2, even at a ventilation rate of 8 AC/h.
However, if in reality, Zur, is 0.0377 m
2/J, then all the calculated fluxes would have to
increase by a factor of ten to achieve the same results. Given that accepted guidelines
(First et al., 1999b) recommend for a room 2.5 m high, one 30 W (input) UV lamp per
18.58 m2 of floor area, which will produce an average flux in the region 50 mW/cm2, this
means that even under this worst-case scenario it should still be possible to achieve
disinfection rates >90% for all but the highest ventilation rates.
When we fixed the UV flux at an average of 50 mW/cm2, we found that for
Zur = 0.377 m
2/J the upper-room UVGI installation produced an equivalent air change
rate of 108.6 AC/h, whereas if Zur = 0.0377 m
2/J this fell to 10.9 AC/h. These values were
constant and unaffected by the actual room ventilation rate.
DISCUSSION
Analysis of the literature relating to the UV irradiation of coronaviruses clearly reveals that
SARS-CoV-2, when in a liquid assay, is relatively easily inactivated by UV light at both
254 nm (Bianco et al., 2020; Signify, 2020) and 280 nm (Inagaki et al., 2020). Indeed,
the results in Table 3 suggest that the virus is likely to be more susceptible to UV-C damage
than either SARS-CoV-1 or MERS-CoV. Furthermore, the results of the experiments
were SARS-CoV-2 was exposed to UV-A/B and riboflavin, suggest that the virus is
susceptible to damage, albeit to a lesser extent, caused by UV light at other wavelengths.
As such, this appears to support the finding of Sagripanti & Lytle (2020) that SARS-CoV-2
is vulnerable to sunlight.
One problem frequently encountered when comparing UV irradiation results from
disparate researchers is that experimenters often utilize different methodologies to
evaluate log reductions in microbial species, with varying doses of UV administered.
In particular, the type of substrate or media used can greatly influence the outcome of
the experiment. This is because the substrate or media can absorb the UV photons and
shield the virus. Given this, it is important to compare like with like, if this is possible.
For this reason we included the results of Heimbuch & Harnish (2019) in Tables 3 and 5,
because they performed the same irradiation experiment on SARS-CoV-1 and MERS-
CoV, as well as on four strains of influenza A, thus allowing direct comparisons to be
made. From Tables 3 and 5 it can be seen that the Z values for the influenza strains are of a
similar order of magnitude as those for the coronaviruses, implying that in this context
SARS-CoV-1 and MERS-CoV were about as difficult to inactivate as influenza A. This is a
surprising finding, because others have suggested that the UV dose required to inactivate
SARS-CoV-2 might be lower than that required to disinfect influenza A (Sagripanti &
Lytle, 2020). This is because coronaviruses have genomes that are approximately twice as
long as that of influenza A, making them in theory much more vulnerable to damage from
UV-C (Sagripanti & Lytle, 2020). Indeed, in a summary collated from hundreds of
published studies by Kowalski (2010), the Z values for influenza A in water were reported
as being in the range 0.04800–0.13810 m2/J, much higher than the values achieved by
Heimbuch & Harnish (2019). As such, this suggests that the substrate or medium in which
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microbes are irradiated plays an important role in influencing the magnitude of the Z value
achieved. Indeed, it is well known in other contexts that UV-C light can be attenuated
as it passes through liquids (Mamane, 2008). When UV light passes through a suspension
of particles in water, its intensity is reduced due to both scattering and absorption of
the light (Gregory, 2005). Absorption occurs because the light beam interacts with atoms
and molecules in the liquid to raise their energy level, with the result that energy is lost
from the beam, whereas scattering occurs when particulates in the fluid interfere with
the UV light making it more diffuse (Mamane, 2008). Particulates can also shield microbes
from UV light. This means that UV inactivation of microbial suspensions in liquid
films >1.2 mm can be greatly inhibited, due to the low penetration depth of UV light
through concentrated suspensions (Cheng et al., 2020). Consequently, when interpreting
the Z values for SARS-CoV-1, SARS-CoV-2 and MERS-CoV in Table 3, it is important to
view them as being strictly contextual.
With regard to UV irradiation of aerosolised viruses, very few published experimental
studies exist, with only three specifically relating to coronaviruses (Buonanno et al., 2020;
Walker & Ko, 2007). As a result there is a paucity of good quality data relating to
UV-C irradiation of SARS-CoV-1, SARS-CoV-2 and MERS-CoV in the air. Consequently,
we had to establish whether or not Walker & Ko (2007) published Z value of 0.377 m2/J
was valid for SARS-CoV-2 in air. Comparison with the Z values presented in Table 3
reveals that this value is considerably greater in magnitude than those achieved for the
coronaviruses when they were irradiated in liquid or on equipment substrates. This
however, is to be expected given that liquids attenuate UV penetration (Mamane, 2008).
Also the finding appears to be broadly in keeping with the behavior of adenoviruses
when irradiated in air and in liquid. Furthermore, because Bedell, Buchaklian & Perlman
(2016) found MERS-CoV to be more susceptible to UV-C damage thanMHV coronavirus,
this strongly supports the use of Walker & Ko (2007) Z value for MHV coronavirus
as a valid surrogate for SARS-CoV-2 in air. Having said this, because the UV susceptibility
of the target microbe is crucial to the performance of any upper-room UVGI
installation, our use of Walker and Ko’s Z value for the MHV coronavirus to represent
SARS-CoV-2 should be treated with caution. For this reason, when we assessed the
performance of the upper-room UVGI in our hypothetical room, we used both 0.377
and 0.0377 m2/J in our simulations. In so doing, we effectively modeled both the expected
and worst-case scenarios.
The results for the expected and worst-case scenarios in Table 7, strongly suggest that
upper-room UVGI, if applied correctly, should be effective at disinfecting SARS-CoV-2
virions suspended in respiratory droplets in the air. This finding is of course very
much dependent on the surrogate Zur value being truly representative for SARS-CoV-2.
With respect to this, one limitation of our study is that we did not distinguish between
the Z values achieved using a single-pass test rig, such as that used byWalker & Ko (2007),
and those achieved in real-life by an upper-room UVGI system. With the latter,
because the irradiation process is fragmented, compared with a single-pass system, it is
thought that higher UV doses might be required to achieve equivalent levels of inactivation
(Beggs et al., 2006; Yang et al., 2017). However, while this specifically applies to aerosolised
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bacteria that can rapidly repair UV damage when the irradiation process becomes
fragmented (Beggs, 2002), it is not known to what extent this applies to viruses, which are
not metabolically active, although it is known that through photoreactivation viruses
can repair UV damage (Weinbauer et al., 1997). Notwithstanding this, because the Z values
achieved for coronaviruses irradiated in air (Buonanno et al., 2020; Walker & Ko, 2007)
are very similar in magnitude to those exhibited by Mycobacterium tuberculosis (the
causative agent of TB) in air (i.e., 0.33–0.48 m2/J (Riley, Knight & Middlebrook, 1976)),
there is good reason to believe that upper-room UVGI might be effective at mitigating the
spread of COVID-19 indoors.
Upper-room UVGI air disinfection is highly dependent on good air mixing
occurring between the upper and lower portions of the room space (Beggs & Sleigh,
2002; Nicas & Miller, 1999; Noakes, Beggs & Sleigh, 2004; Zhu et al., 2013). In the study
presented here we assumed that complete mixing occurred, which although a reasonable
approximation in many instances, is not always the case because short circuiting can
occur (Beggs & Sleigh, 2002). If the room air mixing factor is low, say for example due
stratification in a poorly ventilated space, then this can greatly impair the disinfection
performance of an upper-room UVGI system (Beggs & Sleigh, 2002; Noakes, Beggs &
Sleigh, 2004). It is therefore important when designing such systems to carefully consider
the air movement in the room space, in order to eliminate stagnant regions and maximize
air movement through the UV field. In the context of COVID-19, this is particularly
important because, unlike TB which is spread via the inhalation of droplet nuclei <5 mm
in diameter, it is thought that COVID-19 can be transmitted through the exhalation of
larger respiratory droplets <100 mm, which rapidly reduce in size due to evaporation
(Beggs, 2020; Liu et al., 2017; Xie et al., 2007) to become aerosols, say, <50 mm in diameter
(Nicas, Nazaroff & Hubbard, 2005). These larger aerosol particles have settling velocities
<0.1 m/s and as such can readily be transported on convective room air currents, with
the result that they can remain suspended in room air for many minutes. However, if the
velocities of the convection currents drop, then some of the larger aerosol particles may
decouple from the air stream and settle out due to gravitational deposition, potentially
passing through the breathing zone where they can be inhaled by the room occupants.
This is particularly the case if the air is poorly mixed and stagnant regions exist within the
room space. Under such circumstances larger aerosol particles might be inhaled without
being fully irradiated by the upper-room UV field, undermining the effectiveness of the
whole UVGI installation. Consequently, if upper-room UVGI is to be effective against
COVID-19, it is important to both promote good room air mixing and also ensure that
larger aerosol particles (e.g., <50 mm in diameter) receive the required UV irradiation dose.
As such, this may require upper-room UVGI systems to be supplemented with ceiling
mounted fans (Zhu et al., 2013) or other devices to promote the necessary air movement to
ensure that larger aerosol particles are adequately irradiated.
One major advantage of upper-room UVGI is that it can be retrospectively fitted
into buildings provided that the floor to ceiling height is large enough to ensure that the
UV field does not impinge on room occupants (First et al., 1999b). By installing such a
system it is possible to effectively “turbo-charge” the efficacy of the ventilation system.
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Indeed, in keeping with the findings ofMcDevitt et al. (2008), our analysis suggests that it is
possible to achieve >100 equivalent AC/h by installing upper-room UVGI. Using Eq. (9),
we can calculate the UV rate constant, kuv, which can be thought of as the equivalent air
change rate per second. Once known, this in turn can be used, together with the ventilation
and particulate deposition rate constants, kv, and kd, in Eq. (10), to compute the
concentration of viral partials in the room space at any point in time.
While our analysis has been able to show that upper-room UVGI has the potential to
disinfect the SARS-CoV-2 virus when suspended in room air, we are nonetheless conscious
of the limitations of the feasibility study. Chief among these is the fact that we had to
assume the value of the upper-room UV susceptibility constant, Zur, for SARS-CoV-2.
Although the true value of this constant is likely to be similar to that exhibited by
other aerosolised coronaviruses, we cannot know its exact magnitude without further
experimental work. Consequently, the results of the study should be considered as
indicative only. Also, in the study it was assumed that the room air is well mixed, which, as
discussed above, may not necessarily be the case in some applications. In particular,
because the model used was relatively simple, we were not able to assess how upper-room
UVGI might perform in situations where aerosol particles decouple from the air
stream due to gravitational deposition, or remain suspended in the breath zone. It is
therefore recommended that future studies investigating the use of upper-room UVGI
to prevent COVID-19 transmission use computational fluid dynamics (CFD) to assess the
limitations of the technology with respect to the disinfection of larger aerosol particles that
might decouple from room air convection currents.
CONCLUSIONS
In conclusion, we have been able to demonstrate that the SARS-CoV-2 virus is relatively
easily inactivated by UV-C light and that when aerosolised the virus is likely to have a
UV susceptibility constant, Zur, that is similar to that exhibited by other coronaviruses
in air. This suggests that SARS-CoV-2 when suspended in air should be reasonably easy
to inactivate using UV light at 254 nm. As such, upper-room UVGI may have potential as
an intervention to inhibit the transmission of COVID-19 in buildings, especially in
situations where achieving high ventilation rates might otherwise be impractical.
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